Table 1.
Clinical characteristics of NAFLD patients and normal controls
| Characteristics | NAFLD (n = 12) | Controls (n = 12) | p-value |
|---|---|---|---|
| Gender (F/M) | 9/3 | 9/3 | 1 |
| Age (years) | 41.33 ± 11.36 | 41.00 ± 11.33 | 0.84 |
| WHR | 0.92 ± 0.05 | 0.83 ± 0.04 | < 0.001 |
| BMI (kg/m2) | 26.83 ± 2.78 | 21.44 ± 1.70 | < 0.001 |
| ALT | 45 ± 48.20 | 12.25 ± 4.50 | 0.001 |
| AST | 28.5 ± 18.48 | 19.5 ± 2.84 | 0.31 |
| TC | 5.81 ± 0.70 | 4.67 ± 0.28 | < 0.001 |
| TG | 2.07 ± 1.18 | 0.82 ± 0.24 | < 0.001 |
| FBG | 5.57 ± 0.67 | 4.98 ± 0.33 | 0.009 |
| LDL-C | 3.73 ± 0.63 | 2.97 ± 0.18 | 0.001 |
| HDL-C | 1.29 ± 0.18 | 1.33 ± 0.21 | 0.435 |
BMI body mass index, WHR waist-to-hip ratio, AST serum aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltranspeptidase, FBG serum fasting glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein